Veraxa Biotech AG - Post de-SPAC VRXA Ratios (2024-2025)

NASDAQ VRXA
$1.19 -0.06 (-4.80%)
At close: Oct 1, 2026 · 4:00 PM EDT
Reported Financials

Veraxa Biotech AG - Post de-SPAC Quarterly Ratios

Periods 2 quarters
Latest Dec 2025

Veraxa Biotech AG - Post de-SPAC ratios data for the quarter ended Dec 2025. These financial ratios cover 2 quarters of results from Dec 2024 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2024 Dec2025
Efficiency
Assets AverageAssets Avg. 98.94M
Equity AverageEquity Avg. 7.86M
Invested CapitalInvested Cap. -18.47M
Leverage & Solvency
Debt Ratio 0.01
Valuation
Price to BookP/B 3.97
Enterprise Value 134.50M151.04M
Market Capitalization 140.80M154.45M

Veraxa Biotech AG - Post de-SPAC Ratios API

Pull Veraxa Biotech AG - Post de-SPAC's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VRXA&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY